Next Article in Journal
Use of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses
Next Article in Special Issue
The ‘Ins and Outs’ of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong?
Previous Article in Journal
Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations
Previous Article in Special Issue
Dysregulation of Macropinocytosis Processes in Glioblastomas May Be Exploited to Increase Intracellular Anti-Cancer Drug Levels: The Example of Temozolomide
 
 
Review

Article Versions Notes

Cancers 2019, 11(3), 417; https://doi.org/10.3390/cancers11030417
Action Date Notes Link
article xml file uploaded 24 March 2019 05:45 CET Original file -
article xml uploaded. 24 March 2019 05:45 CET Update -
article pdf uploaded. 24 March 2019 05:45 CET Version of Record https://www.mdpi.com/2072-6694/11/3/417/pdf-vor
article html file updated 24 March 2019 05:47 CET Original file -
article xml file uploaded 25 March 2019 13:21 CET Update -
article xml uploaded. 25 March 2019 13:21 CET Update https://www.mdpi.com/2072-6694/11/3/417/xml
article pdf uploaded. 25 March 2019 13:21 CET Updated version of record https://www.mdpi.com/2072-6694/11/3/417/pdf
article html file updated 25 March 2019 13:22 CET Update -
article html file updated 4 April 2019 19:03 CEST Update -
article html file updated 9 April 2019 18:28 CEST Update -
article html file updated 11 April 2019 17:31 CEST Update -
article html file updated 25 April 2019 22:24 CEST Update -
article html file updated 17 October 2019 02:49 CEST Update -
article html file updated 12 February 2020 00:26 CET Update -
article html file updated 19 July 2022 16:47 CEST Update https://www.mdpi.com/2072-6694/11/3/417/html
Back to TopTop